Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lene Ryom

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Plos Medicine|April 1, 2015
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.
The Journal of Infectious Diseases|August 4, 2016
Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D StudyLene Ryom, Jens D Lundgren, Mike Ross, et al.
European Journal of Preventive Cardiology|April 18, 2015
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) studyNina Friis-Møller, Lene Ryom, Colette Smith, et al.
Journal of the International AIDS Society|March 7, 2018
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D StudyCamilla I Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.
AIDS (London, England)|January 12, 2016
Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive personsLene Ryom, Jens Dilling Lundgren, Stéphane De Wit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2012
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs studyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
Open Forum Infectious Diseases|March 1, 2016
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
Antiviral Therapy|April 27, 2016
Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D studyDavid A Kamara, Colette Smith, Lene Ryom, et al.
Journal of the National Cancer Institute|December 22, 2017
Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin LymphomaLeah Shepherd, Lene Ryom, Matthew Law, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 18, 2025
Low Trauma Fractures in People with HIV: Longitudinal Time Trends in the Swiss HIV Cohort Study 2009-2022Isabella C Schoepf, Vera Baltisberger, Christian W Thorball, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Plos Medicine|April 1, 2015
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.
The Journal of Infectious Diseases|August 4, 2016
Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D StudyLene Ryom, Jens D Lundgren, Mike Ross, et al.
European Journal of Preventive Cardiology|April 18, 2015
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) studyNina Friis-Møller, Lene Ryom, Colette Smith, et al.
Journal of the International AIDS Society|March 7, 2018
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D StudyCamilla I Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.
AIDS (London, England)|January 12, 2016
Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive personsLene Ryom, Jens Dilling Lundgren, Stéphane De Wit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2012
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs studyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
Open Forum Infectious Diseases|March 1, 2016
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
Antiviral Therapy|April 27, 2016
Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D studyDavid A Kamara, Colette Smith, Lene Ryom, et al.
Journal of the National Cancer Institute|December 22, 2017
Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin LymphomaLeah Shepherd, Lene Ryom, Matthew Law, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 18, 2025
Low Trauma Fractures in People with HIV: Longitudinal Time Trends in the Swiss HIV Cohort Study 2009-2022Isabella C Schoepf, Vera Baltisberger, Christian W Thorball, et al.
Pageof 11